Glaucoma 360 New Horizons Forum

Healio brings you the highlights from Glaucoma 360 New Horizons Forum. Refer back to this page often for the latest news from Glaucoma 360, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Chambers explains FDA’s rationale for clinical trial requirements

February 18, 2020
SAN FRANCISCO — Ensuring safe and effective products are available to the American people is the mission of the FDA Center for Drug Evaluation…
Meeting NewsVideo

VIDEO: Aerie updates Rhopressa, Rocklatan programs

February 18, 2020
SAN FRANCISCO — At Glaucoma 360: New Horizons Forum, Thomas A. Mitro, president and chief operating officer of Aerie Pharmaceuticals, updates…
Meeting NewsVideo

VIDEO: Novel drug aims to lower episcleral venous pressure to treat glaucoma

February 17, 2020
SAN FRANCISCO — At Glaucoma 360: New Horizons Forum, Thurein Htoo, MS, MBA, CEO of Qlaris Bio, discusses how the company is targeting…
Meeting NewsVideo

VIDEO: ReNetX Bio’s neuroprotection technology promising for glaucoma treatment

February 14, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, James C. Tsai, MD, MBA, president of New York Eye and Ear Infirmary of Mount Sinai…
Meeting NewsVideo

VIDEO: Neurotech implant shows positive safety profile

February 13, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at Byers Eye…
Meeting NewsVideo

VIDEO: Aerie to test Rho kinase inhibitor implant for glaucoma

February 13, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Casey C. Kopczynski, PhD, chief scientific officer and co-founder of Aerie…
Meeting NewsVideo

VIDEO: Berdahl gives tips to entrepreneurship success

February 12, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, John P. Berdahl, MD, discusses how to bring a product from an idea to market success.
Meeting NewsVideo

VIDEO: One-second laser treatment could allow glaucoma specialists to treat more patients

February 11, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Daria Lemann-Blumenthal, LLB, EMBA, CEO of Belkin Laser, discusses the…
Meeting News

Preliminary data show intracameral implant reduces IOP up to 9 months

February 11, 2020
SAN FRANCISCO — An intracameral travoprost implant reduced IOP for up to 9 months in preliminary results from a phase 1 study, according to a…
Meeting News

iDose lowers IOP, shows no significant adverse events in phase 2 trial

February 10, 2020
SAN FRANCISCO — The iDose, a titanium implant from Glaukos for continuous drug delivery, has shown positive phase 2 results and is currently in…

Meeting Calendar

Glaucoma 360 New Horizons Forum

January 29, 2021

  • Location: San Francisco, California
  • Website